Envista Holdings Corp (NVST)
19.02
+0.02
(+0.11%)
USD |
NYSE |
May 06, 10:54
Envista Holdings SG&A Expense (Quarterly): 284.90M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 284.90M |
December 31, 2023 | 260.20M |
September 30, 2023 | 257.70M |
June 30, 2023 | 272.90M |
March 31, 2023 | 266.10M |
December 31, 2022 | 253.60M |
September 30, 2022 | 264.20M |
June 30, 2022 | 279.50M |
March 31, 2022 | 258.20M |
December 31, 2021 | 272.30M |
September 30, 2021 | 250.60M |
June 30, 2021 | 259.40M |
March 31, 2021 | 237.50M |
Date | Value |
---|---|
December 31, 2020 | 243.30M |
September 30, 2020 | 226.80M |
June 30, 2020 | 241.90M |
March 31, 2020 | 268.70M |
December 31, 2019 | 175.50M |
September 30, 2019 | 252.00M |
June 30, 2019 | 278.00M |
March 31, 2019 | 274.90M |
December 31, 2018 | 311.00M |
September 30, 2018 | 257.20M |
June 30, 2018 | 278.00M |
March 31, 2018 | 285.20M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
175.50M
Minimum
Dec 2019
284.90M
Maximum
Mar 2024
255.16M
Average
258.80M
Median
SG&A Expense (Quarterly) Benchmarks
Boston Scientific Corp | 1.364B |
Dentsply Sirona Inc | 417.00M |
Biolase Inc | 6.948M |
Milestone Scientific Inc | 3.301M |
Wellness Center USA Inc | -- |